Docoh
Loading...

INIS International Isotopes

International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. It operates through the following segments: Radiochemical Products, Cobalt Products, Nuclear Medicine Products, Radiological Services and Fluorine Products. The Radiochemical Products segment includes production and distribution of various isotopically pure radio chemicals for medical, industrial, or research applications. The Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for tele therapy or irradiation devices, and recycling of expended cobalt sources. The Nuclear Medicine Products segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Radiological Services Segment concerns a wide array of miscellaneous services that consists of gemstone processing and field services that include source installation, removal, and radiation device decommissioning. The Fluorine Product segment involved the production of small scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. International Isotopes was founded in November 1995 and is headquartered in Idaho Falls, ID.

INIS stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

17 May 21
24 Jun 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 1.24M 1.24M 1.24M 1.24M 1.24M 1.24M
Cash burn (monthly) 168.93K (positive/no burn) 150.18K 54.74K 97.77K (positive/no burn)
Cash used (since last report) 470.54K n/a 418.31K 152.48K 272.32K n/a
Cash remaining 774.37K n/a 826.6K 1.09M 972.59K n/a
Runway (months of cash) 4.6 n/a 5.5 20.0 9.9 n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
28 Feb 21 Steve Laflin Common Stock Payment of exercise Dispose F No No 0.143 77,489 11.08K 8,401,264
28 Feb 21 Steve Laflin Common Stock Grant Aquire A No No 0 195,804 0 8,478,753
20 Jan 21 W Matthew Cox Common Stock Payment of exercise Dispose F No No 0.28 13,393 3.75K 49,107
20 Jan 21 W Matthew Cox Common Stock Option exercise Aquire M No No 0.06 62,500 3.75K 62,500
20 Jan 21 W Matthew Cox Stock Option Common Stock Option exercise Dispose M No No 0.06 62,500 3.75K 187,500
20 Jan 21 Christopher G Grosso Common Stock Payment of exercise Dispose F Yes No 0.28 75,000 21K 158,333
20 Jan 21 Christopher G Grosso Common Stock Option exercise Aquire M Yes No 0.12 175,000 21K 233,333
20 Jan 21 Christopher G Grosso Common Stock Payment of exercise Dispose F Yes No 0.28 75,000 21K 158,333
20 Jan 21 Christopher G Grosso Common Stock Option exercise Aquire M Yes No 0.12 175,000 21K 233,333
20 Jan 21 Christopher G Grosso Common Stock Payment of exercise Dispose F No No 0.28 2,496,966 699.15K 32,783,959

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

50.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1 1
Opened positions 1 1
Closed positions 1 0 NEW
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 11.74M 1K +1174200.0%
Total shares 230.26M 20K +1151189.8%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Kennerman Associates 230.26M $11.74M NEW
Largest transactions
Shares Bought/sold Change
Kennerman Associates 230.26M +230.26M NEW
Capital Square 0 -20K EXIT
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: claim, commonly, disrupted, exempt, exposure, final, Frequently, higher, individual, key, main, margin, matter, middle, notification, practice, predominant, pursuing, random, receipt, reimburse, restored, settlement, shutdown
Removed: adding, adjusted, Agency, allocated, Atomic, attributed, aware, began, cancelling, capacity, combined, counterparty, evaluate, existed, Food, formally, forward, generated, IAEA, launched, length, measuring, modify, older, ongoing, party, pending, putting, recoup, residual, resulted, rollout, startup, threatened, underway